A role for rhodopsin in a signal transduction cascade that regulates membrane trafficking and photoreceptor polarity  by Deretic, Dusanka
Vision Research 46 (2006) 4427–4433
www.elsevier.com/locate/visresA role for rhodopsin in a signal transduction cascade that regulates 
membrane traYcking and photoreceptor polarity
Dusanka Deretic ¤
Department of Surgery, Division of Ophthalmology, University of New Mexico, Albuquerque, NM 87131, USA
Department of Cell Biology and Physiology, University of New Mexico, Albuquerque, NM 87131, USA
Received 25 May 2006; received in revised form 24 July 2006
Abstract
This review summarizes the most recent progress in the understanding of the role of rhodopsin C-terminal domain in the regulation of
intracellular traYcking and photoreceptor morphogenesis. A proposed cascade of molecular interactions, initiated by the rhodopsin C-
terminal sequence VXPX-COOH during traYcking from the Golgi/TGN in retinal photoreceptors, is relayed by the small GTPase ARF4
to the downstream eVectors. One of the candidates for an ARF4 eVector is the ARF-GAP ASAP1, which may function as a subunit of, or
form a novel protein coat involved in traYcking from the TGN and in cytoskeletal remodeling, whose assembly is regulated by the
binding of ARF4 to rhodopsin, and whose function is essential for the polarized traYcking toward the ROS.
© 2006 Elsevier Ltd. All rights reserved.
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The rod outer segment (ROS)1, a photoreceptor-speciWc
organelle elaborated from a modiWed primary cilium,
encloses a stack of approximately 1000 Xattened disk mem-
branes with 104–106 molecules of rhodopsin/disk. In this
environment rhodopsin functions as the light receptor,
which activates the phototransduction cascade resulting in
membrane hyperpolarization and inhibition of synaptic
transmission (Burns & Arshavsky, 2005; Chen, 2005; Ridge,
Abdulaev, Sousa, & Palczewski, 2003). Like other mem-
brane proteins, rhodopsin is synthesized in the ER, and fur-
ther modiWed in the Golgi. These biosynthetic organelles
are localized in the cell body, the rod inner segment (RIS),
thus necessitating the long-distance movement of newly
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doi:10.1016/j.visres.2006.07.028synthesized rhodopsin on post-Golgi membranes toward
ROS. They fuse with the plasma membrane surrounding
the connecting cilium through which rhodopsin is delivered
to the ROS.
Vectorial transport of rhodopsin on vesicles was Wrst
described in the 1980s (Besharse & Pfenninger, 1980;
Defoe & Besharse, 1985; Papermaster, Schneider, &
Besharse, 1985; Papermaster, Schneider, Defoe, & Besh-
arse, 1986). Post-Golgi vesicles were subsequently isolated
and their characterization was initiated in the 1990s
(Deretic & Papermaster, 1991). As recent studies using
live microscopy in a variety of cell types revealed that
post-Golgi carriers are large pleiomorphic structures,
rather than the small vesicles, as previously believed (Hir-
schberg et al., 1998; Toomre, Steyer, Keller, Almers, &
Simons, 2000), we re-named post-Golgi vesicles rhodopsin
transport carriers (RTCs). Molecular interactions
depicted in Fig. 1 are essential for the generation of, and
incorporation of rhodopsin into, RTCs that are properly
targeted and rendered competent for fusion with the RIS
plasma membrane.
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adRP mutations
Convergent evidence points to the four highly conserved
carboxyl terminal amino acids of rhodopsin as the most
important determinant for its incorporation into RTCs,
correct intracellular targeting and ROS localization (Con-
cepcion, Mendez, & Chen, 2002; Deretic, Schmerl, Har-
grave, Arendt, & McDowell, 1998; Tam, Moritz, Hurd, &
Papermaster, 2000). Our studies using the retinal cell-free
system that reconstitutes RTC budding from the central
sorting organelle of the cell, the trans-Golgi network
(TGN), identiWed the last Wve amino acids of rhodopsin as
the essential targeting sequence (Deretic et al., 1998). In this
assay, RTC budding was inhibited by a monoclonal anti-
rhodopsin antibody 11D5, whose antigenic site is within the
Wve C-terminal amino acids, and by synthetic peptides cor-
responding to the C-terminus of rhodopsin (Deretic, Puleo
Scheppke, & Trippe, 1996; Deretic et al., 1998). Collectively,
recent studies from several groups point to the minimal
essential targeting sequence, VXPX-COOH, which inter-
acts with the traYcking machinery thereby assuring correct
delivery of rhodopsin (Deretic, 2004).
The integrity of the rhodopsin C-terminal targeting sig-
nal VXPX-COOH is crucial for photoreceptor survival.
Mutations that aVect this highly conserved motif cause par-
ticularly severe forms of the neurodegenerative diseaseautosomal dominant retinitis pigmentosa (adRP), with a
signiWcantly faster rate of progression than the adRP
caused by other rhodopsin mutations (Berson, Rosner,
Weigel-DiFranco, Dryja, & Sandberg, 2002). The severity
of the disease allele suggests that the rhodopsin C-terminal
domain participates in important cellular processes distinct
from phototransduction. The accessibility of this domain is
crucial for macromolecular interactions and a Ter349Glu
mutation, which is predicted to add an additional 51 amino
acids to the C-terminus, renders rhodopsin dysfunctional
and causes one of the most severe adRP phenotypes
described to date (Bessant et al., 1999). A newly described
Ter349Gln adRP variant, which is predicted to add an
additional segment of 58 amino acids, is highly likely to be
pathogenic as well (Sullivan et al., 2006). V345, A346
and P347 are the sites of C-terminal adRP mutations
involving single amino acid substitutions (http://www.
retina-international.com/sci-news/rhomut.htm), highlight-
ing their importance for photoreceptor viability.
The C-terminal rhodopsin mutations responsible for
adRP were suggested to inhibit its interaction with Tctex-1,
a ubiquitous light chain of the molecular motor cytoplas-
mic dynein (Tai, Chuang, Bode, Wolfrum, & Sung, 1999),
but, taken together, studies by the same group revealed that
the rhodopsin VXPX-COOH sequence is completely dis-
pensable for Tctex-1 binding (Chuang & Sung, 1998; Tai,
Chuang, & Sung, 2001). Thus, it remains controversial if theFig. 1. Molecular interactions essential for the generation of, and incorporation of rhodopsin into, RTCs. (A) Rhodopsin transport carriers (RTCs) move
vectorially (dashed arrow) from the Golgi (G)/TGN, through the ellipsoid region Wlled with mitochondria (M), to the connecting cilium (C), where they
fuse with the plasma membrane of the RIS. Newly synthesized rhodopsin is then delivered to the ROS. N, nucleus; Sy, synapse. (B) RTC budding from the
TGN is regulated by the small GTPases rab6 and rab11 (Deretic et al., 1996). Rhodopsin C-terminal binds to, and recruits ARF4 to the TGN membrane
and this process is essential for RTC budding (Deretic et al., 2005). ARF-GAP ASAP1 is currently investigated as a candidate for the novel coat protein
that regulates RTC budding. RTC fusion at the connecting cilium is regulated by PI(4, 5)P2, actin, moesin, rho-GDI, and the GTPases rac1 and rab8
(Deretic et al., 1995; Deretic et al., 2004; Moritz et al., 2001). Mutations in rab8 inhibit RTC fusion, cause accumulation of RTCs and retinal degeneration.
(C) In healthy polarized photoreceptors, expressing two copies of the Wt rhodopsin gene, rhodopsin is sorted in the TGN, incorporated into RTCs, deliv-
ered to, and retained in the ROS. In animal models of adRP caused by rhodopsin C-terminal mutations Wt rhodopsin retains its normal subcellular local-
ization in the ROS. By contrast, rhodopsin in which the sorting signal is ablated or mutated, loses its capacity to be recognized by, and to interact with the
appropriate sorting machinery at the TGN. Consequentially, mutant rhodopsin follows the “bulk Xow” of the membrane arriving randomly to the ROS,
RIS and the synapse.
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rhodopsin targeting through the VXPX-COOH sorting sig-
nal, whose disruption in rod photoreceptors leads to patho-
logical changes in animal models and in patients with
adRP.
3. The NPXXY and the FR motifs are potential regulators of 
rhodopsin traYcking
In addition to the VXPX-COOH sequence, rhodopsin
contains at least two putative sorting signals whose func-
tion has not been explored (Fig. 2). First, it contains the
NPXXY motif in the cytoplasmic domain of the seventh
transmembrane helix, known in other G-protein coupled
receptors (GPCRs) as the binding site for ADP-ribosyla-
tion factor (ARF) GTPases (Mitchell et al., 1998; Robert-
son et al., 2003). ARFs are important regulators of
membrane traYcking responsible for the recruitment of
coat proteins, lipid modifying enzymes and actin cytoskele-
ton regulators, cooperatively aVecting membrane curvature
and sorting of cargo molecules into membrane carriers
(Donaldson & Jackson, 2000; Nie, Hirsch, & Randazzo,
2003). Second, the cytoplasmic helix H8 of rhodopsin con-
tains a highly conserved ciliary targeting signal, the FR
motif (Corbit et al., 2005). Therefore, even rhodopsin with
impaired or deleted primary targeting sequence VXPX-
COOH retains some information directing its subcellular
localization. The existence of the secondary sorting signal,
recently implicated in ciliary targeting, underscores the
Fig. 2. Schematic representation of the rhodopsin C-terminal domain
(modiWed from (Palczewski et al., 2000), where key residues were shown in
black Wlled circles and residues not modeled in the crystal structure in
green Wlled circles). The VXPX C-terminal sequence is a hot spot for
mutations causing adRP, indicated in red, and listed in the Wgure. Like-
wise, changes in the termination codon, predicted to add additional amino
acids to the C-terminus, lead to adRP. The C-terminal sequence is the
antigenic site of the inhibitory mAb 11D5 (Deretic et al., 2005). Two addi-
tional domains, possibly involved in interaction with ARF GTPases (helix
7), and in ciliary targeting (helix 8), are circled in red. Truncation muta-
tion disrupting the putative ciliary targeting sequence also results in adRP.importance of dissecting the hierarchy of signals responsi-
ble for the delivery of rhodopsin to ROS.
4. Rhodopsin mislocalization, not the absence of rhodopsin in 
the ROS, is the likely cause of adRP caused by 
the C-terminal mutations
Phototransduction is not disrupted in animal models of
rhodopsin adRP mutants aVecting the VXPX-COOH
sequence (Osawa & Weiss, 1994; Weiss et al., 1995). Rather,
the defective recognition of rhodopsin bearing the C-termi-
nal adRP mutations results in mistargeting due to abnor-
mal incorporation of mutant rhodopsin into RTCs, likely
leading to pathological changes in photoreceptor cells in
patients with adRP. This was documented in transgenic
mice (Li, Snyder, Olsson, & Dryja, 1996; Sung, Makino,
Baylor, & Nathans, 1994), as well as in transgenic rats and
pigs carrying adRP mutations in the sorting signal in rho-
dopsin, or transgenic frogs carrying the same mutations in
GFP-rhodopsin-C-terminal fusion proteins, where the
absence of the correct sorting information resulted in
mistargeting to the RIS plasma membrane and the synapse
in vivo (Green, Menz, LaVail, & Flannery, 2000; Li et al.,
1998; Tam et al., 2000). In the S334ter rhodopsin transgenic
rat model of adRP mutant rhodopsin represents only
»10% of the total, yet the RIS plasma membrane labeling is
20-fold higher than in wild-type rats, and the rate of cell
death directly correlates with the severity of missorting of
mutant rhodopsin (Green et al., 2000). This mechanism is
diVerent from the pathology caused by the folding-deWcient
rhodopsin N-terminal mutants, which induce aggregation
and degradation by the ubiquitin proteasome system and
aVect the maturation of the wild-type (Wt) rhodopsin
(Rajan & Kopito, 2005; Saliba, Munro, Luthert, & Chee-
tham, 2002). The Wt rhodopsin is unaVected by the folding-
proWcient C-terminal adRP mutants and retains its correct
localization in all animal models reported to date. The
potential eVect of mutant rhodopsin lacking the C-terminal
sorting signal on the localization of other putative
membrane or soluble cargo normally carried by RTCs is
presently unknown.
Rhodopsin bearing the C-terminal adRP mutations is
impaired in its interactions with the sorting machinery and
is likely to incorporate indiscriminately, by “bulk Xow”,
into post-Golgi carriers destined for diVerent subcellular
domains, not only into RTCs. This results in the random
delivery of mutant rhodopsin to all photoreceptor domains
actively receiving new membrane, including the ROS, as
illustrated in Fig. 1C. This untargeted and unregulated
delivery clearly favors the ROS, due to the exceptionally
high magnitude of new membrane addition. When ran-
domly delivered to the ROS, C-terminal mutants are not
expected to cause signiWcant disruption, since they retain
light-dependent function and do not interfere with Wt rho-
dopsin. However, mislocalization of even a fraction of rho-
dopsin, which represents 90% of newly synthesized protein
in photoreceptor cells, is likely detrimental to the function
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rhodopsin. Ectopic expression of the large quantity of
mutant rhodopsin is likely to signiWcantly alter the physical
properties, the composition and the function of aVected
membranes. The injury caused by the continuous delivery
of mutant rhodopsin to non-native membranes is further
compounded by the absence of the mechanism for its elimi-
nation, since sequestration and endocytosis, the mecha-
nisms utilized for the removal of other GPCRs, are not
employed by vertebrate rhodopsin, which is normally
removed only through ROS disk shedding and phagocyto-
sis by retinal pigment epithelial (RPE) cells.
Accumulation of mutant rhodopsin triggers interactions
that lead to pathological changes in photoreceptor cells,
which are followed by apoptotic cell death and retinal
degeneration. All rhodopsin C-terminal adRP mutants
mislocalize in photoreceptor cells, and it is this mislocaliza-
tion, rather than the absence of rhodopsin in the ROS, that
is the likely cause of the disease. It has been proposed that
the light activation of the mislocalized mutant rhodopsin
causes retinal degeneration, but recent studies clearly dem-
onstrate that retinal degeneration is independent of light
activation (Tam, Xie, Oprian, & Moritz, 2006). A more
likely cause of rod cell death is the membrane crowding,
particularly at the synapse, caused by the build-up of mislo-
calized mutant rhodopsin. Fusion of synaptic vesicles with
the plasma membrane is tightly coupled to endocytosis of
vesicle constituents that are continuously recycled for fur-
ther use (Ryan, 2006). This task is particularly challenging
for neurons Wring for sustained periods, such as rod photo-
receptors. The accumulation of mutant rhodopsin likely
interferes with the dynamic remodeling of the synapse and
causes neurite outgrowth in adRP patients and in animal
models (Li, Kljavin, & Milam, 1995; Li et al., 1998; Tam
et al., 2006), suggesting a dominant negative eVect on syn-
aptic membrane turnover that may underlie the dominant
inheritance of adRP.
5. Rhodopsin C-terminus also regulates photoreceptor 
morphogenesis
Expression of rhodopsin is required for photoreceptor
morphogenesis, since photoreceptors lacking rhodopsin fail
to elaborate light-sensitive membranes and degenerate in
humans and in animal models (Humphries et al., 1997;
Rosenfeld et al., 1992). Rhodopsin replacement restores
normal retinal morphology (McNally et al., 1999). How-
ever, replacement of mouse rhodopsin with GFP-C-termi-
nally-tagged human rhodopsin causes defects in
photoreceptor morphogenesis and retinal degeneration,
(Chan, Bradley, Wensel, & Wilson, 2004), partially mimick-
ing the Ter349Glu adRP mutation, which aVects the avail-
ability of the rhodopsin C-terminal targeting sequence for
molecular interactions. Conversely, transgenic mice
expressing truncated rhodopsin missing the C-terminal
domain, on the rhodopsin-null background, do not form
ROS (Concepcion et al., 2002). Expression of mouseS-opsin, with conserved targeting sequence VXPX-COOH,
on the same background, restores ROS morphogenesis
(Shi, Concepcion, & Chen, 2004). Therefore, the recogni-
tion of the C-terminal targeting sequence not only directs
intracellular traYcking, but also triggers the onset of ROS
morphogenesis. The molecular mechanisms by which the
rhodopsin C-terminal targeting motif initiates ROS mor-
phogenesis are not clear at present, but the small GTPases
and their interacting proteins are emerging as candidate
regulatory molecules involved in these processes.
6. Rhodopsin C-terminus regulates traYcking by direct 
binding to the small GTPase ARF4
Our recent study documents direct and speciWc functional
association between the small GTPase ARF4 and the rho-
dopsin targeting sequence, VXPX-COOH, which is essential
for its sorting into RTCs and its polarized traYcking
(Deretic et al., 2005). The molecular machinery underlying
regulation of membrane traYc by ARF GTPases has been
elucidated for the class I ARFs (ARFs 1–3), but the function
of class II ARFs (ARFs 4 and 5) remains largely obscure. In
their GTP-bound form ARFs bind to membranes to recruit
coat proteins. Subsequent GTP-hydrolysis assisted by
GTPase-activating proteins, ARF-GAPs, is coupled to cargo
sorting, formation of transport carriers and concomitant
release of ARF-GDP from the membranes. Recent study
suggests that a cooperation of two ARFs at the same site
may be a common feature in their regulation of membrane
traYcking (Volpicelli-Daley, Li, Zhang, & Kahn, 2005). We
have established that ARF4 regulates RTC budding from
the Golgi/TGN by direct binding to rhodopsin C-terminus. It
remains to be determined if ARF4 cooperates with a class I
ARF, which may bind to the NPXXY motif.
The exclusion of ARF4 from the ROS rules out a role for
ARF4 in the visual transduction cascade. The intracellular
distribution of ARF4 in photoreceptors is consistent with its
interaction with rhodopsin during RTC membrane budding,
indicating that the Golgi/TGN is the site of interaction of
newly synthesized rhodopsin and ARF4. Further, the anti-
ARF4 antibody and the peptide corresponding to the  helix
3 of ARF4, which was used to generate the anti-ARF4 anti-
body, inhibit RTC budding in the in vitro assay to the same
extent as the anti-rhodopsin mAb 11D5 and the rhodopsin
C-terminal peptide (Deretic et al., 2005). Thus, the eVects of
blocking ARF4 action are functionally equivalent to the
eVects of blocking the rhodopsin C-terminal sorting signal.
By extension, our data suggest that the failure of rhodopsin
C-terminal adRP mutants to bind to ARF4 results in their
omission from RTCs, and missorting to the RIS plasma
membrane and synapse, as seen in animal models.
7. Rhodopsin-ARF4 interaction may provide spatio-temporal 
control of the ARF4-GTPase reaction
Our data also raise a possibility that the  helix 3 of
ARF4 is involved in the direct interaction with the rhodopsin
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blocks the access of the rhodopsin C-terminal tail, and of
the coat proteins to ARF4. Bound anti-ARF4 antibody
could prevent GTP hydrolysis and cause longer residency
time of ARF4 on the Golgi membranes, thus inhibiting
budding of RTCs. In preliminary experiments we have
detected an increase in membrane association of ARF4 fol-
lowing incubation with anti-ARF4 antibody. The mem-
brane residency time of ARF4 on the Golgi/TGN could be
controlled by the rhodopsin C-terminus, which may regu-
late the access of an unknown ARF-GAP to ARF4. Thus,
rhodopsin, possibly in conjunction with the TGN coat pro-
teins may regulate the ARF4-GTPase reaction, which is
necessary for RTC budding.
8. ARF-GAP ASAP1 is a strong candidate for the novel 
protein coat recruited by ARF4 and involved in rhodopsin 
traYcking and cytoskeletal remodeling
To identify the ARF-GAP that acts on ARF4, and to
explore the involvement of ARF-GAPs in rhodopsin
traYcking, we have determined that photoreceptor cells
express high levels of an ARF-GAP ASAP1 (Astuto-Grib-
ble, Mazelova, Ransom, Inoue, Randazzo & Deretic, man-
uscript in preparation). ASAP1 is a member of a family of
multifunctional proteins that regulate membrane traYc and
actin remodeling (Brown et al., 1998; Che et al., 2005; Ran-
dazzo & Hirsch, 2004). Our preliminary data show that
ARF4 cooperates with previously identiWed small GTPase
rab11 (Deretic et al., 1996) to control membrane traYcking
toward ROS. ARF4 and rab11 likely exert control over
each other through arfophilins, the multifunctional regula-
tory ARF/rab11 binding proteins (Meyers & Prekeris,
2002; Shin, Couvillon, & Exton, 2001; Shin, Ross, Mihai, &
Exton, 1999). ARF4 is released from the membrane during
RTC budding, ASAP1 dissociates after budding, while
rab11 remains associated with RTCs. This sequence of
events suggests that ASAP1 may function as a subunit of,
or form a novel protein coat recruited by ARF4, regulated
by rab11, and involved in rhodopsin traYcking from the
TGN. ASAP1 contains numerous protein–protein and pro-
tein–lipid interaction domains (Nie et al., 2006; Nie & Ran-
dazzo, 2006; Randazzo & Hirsch, 2004). Thus, ASAP1
recruited to the Golgi/TGN by the rhodopsin/ARF4 inter-
action, may act as a signaling platform for large molecular
complexes, including cytoskeleton regulators. The coordi-
nated macromolecular assembly may insure the generation
of fusion-competent RTCs, depicted in Fig. 1B, by linking
RTC budding with the recruitment of the molecular
machinery, including lipid modifying enzymes, moesin and
the GTPases rac1 and rab8 (Deretic et al., 2004), necessary
for actin polymerization and subsequent RTC fusion.
The cascade of interactions initiated by the recognition
of the rhodopsin C-terminal targeting sequence upon its
expression in photoreceptor cells is likely to regulate not
only rhodopsin traYcking but also to shape and organize
the TGN, promote polarized membrane transport throughreorganization of membrane cytoskeleton, and direct the
traYcking of molecular components involved in photore-
ceptor morphogenesis and the development of ROS.
9. Neurodegenerative diseases are often caused by the 
breakdown of membrane–cytoskeleton interactions
Terminally diVerentiated neuronal cells are highly sus-
ceptible to traYcking defects, which frequently cause neu-
rodegenerative disorders. The number of proteins involved
in rhodopsin traYcking aVected by disease-causing muta-
tions is continuously growing. Our studies identiWed the
small GTPase rab8 as an essential component of the
machinery that is involved in RTC docking and fusion with
the plasma membrane (Deretic et al., 1995; Moritz et al.,
2001). Experimental manipulation of rab8-dependent path-
ways, through the introduction of mutant rab8 into photo-
receptors of transgenic frogs, causes severe retinal
degeneration (Moritz et al., 2001). Interestingly, rab8 inter-
acting proteins Optineurin and Huntingtin, are linked to
neurodegenerative diseases primary open angle glaucoma
(POAG) and Huntington’s disease, respectively (Faber
et al., 1998; Hattula & Peranen, 2000; Rezaie et al., 2002;
Sahlender et al., 2005). Rab8, Optineurin and Huntingtin
are collectively involved in the linkage of membrane organ-
elles to the cytoskeleton (Sahlender et al., 2005), suggesting
that the breakdown of this linkage may be a common
theme in retinal degeneration and in other neurodegenera-
tive diseases. In that light, elucidation of the function of
rhodopsin in membrane traYcking and photoreceptor mor-
phogenesis through the recruitment of ARF4, and the cyto-
skeletal regulator ARF-GAP ASAP1, may shed new light
on the mechanism of retinal degeneration caused by car-
boxyl-terminal adRP mutations in rhodopsin.
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